1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Healthcare Nanotechnology (Nanomedicine) Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 Nanomedicine 1.2.3 Nano Medical Devices 1.2.4 Nano Diagnosis 1.2.5 Other 1.3 Market by Application 1.3.1 Global Healthcare Nanotechnology (Nanomedicine) Market Share by Application: 2017 VS 2021 VS 2028 1.3.2 Anticancer 1.3.3 CNS Product 1.3.4 Anti-infective 1.3.5 Other 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Healthcare Nanotechnology (Nanomedicine) Market Perspective (2017-2028) 2.2 Healthcare Nanotechnology (Nanomedicine) Growth Trends by Region 2.2.1 Healthcare Nanotechnology (Nanomedicine) Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Healthcare Nanotechnology (Nanomedicine) Historic Market Size by Region (2017-2022) 2.2.3 Healthcare Nanotechnology (Nanomedicine) Forecasted Market Size by Region (2023-2028) 2.3 Healthcare Nanotechnology (Nanomedicine) Market Dynamics 2.3.1 Healthcare Nanotechnology (Nanomedicine) Industry Trends 2.3.2 Healthcare Nanotechnology (Nanomedicine) Market Drivers 2.3.3 Healthcare Nanotechnology (Nanomedicine) Market Challenges 2.3.4 Healthcare Nanotechnology (Nanomedicine) Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Healthcare Nanotechnology (Nanomedicine) Players by Revenue 3.1.1 Global Top Healthcare Nanotechnology (Nanomedicine) Players by Revenue (2017-2022) 3.1.2 Global Healthcare Nanotechnology (Nanomedicine) Revenue Market Share by Players (2017-2022) 3.2 Global Healthcare Nanotechnology (Nanomedicine) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Healthcare Nanotechnology (Nanomedicine) Revenue 3.4 Global Healthcare Nanotechnology (Nanomedicine) Market Concentration Ratio 3.4.1 Global Healthcare Nanotechnology (Nanomedicine) Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Healthcare Nanotechnology (Nanomedicine) Revenue in 2021 3.5 Healthcare Nanotechnology (Nanomedicine) Key Players Head office and Area Served 3.6 Key Players Healthcare Nanotechnology (Nanomedicine) Product Solution and Service 3.7 Date of Enter into Healthcare Nanotechnology (Nanomedicine) Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Healthcare Nanotechnology (Nanomedicine) Breakdown Data by Type 4.1 Global Healthcare Nanotechnology (Nanomedicine) Historic Market Size by Type (2017-2022) 4.2 Global Healthcare Nanotechnology (Nanomedicine) Forecasted Market Size by Type (2023-2028) 5 Healthcare Nanotechnology (Nanomedicine) Breakdown Data by Application 5.1 Global Healthcare Nanotechnology (Nanomedicine) Historic Market Size by Application (2017-2022) 5.2 Global Healthcare Nanotechnology (Nanomedicine) Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Healthcare Nanotechnology (Nanomedicine) Market Size (2017-2028) 6.2 North America Healthcare Nanotechnology (Nanomedicine) Market Size by Country (2017-2022) 6.3 North America Healthcare Nanotechnology (Nanomedicine) Market Size by Country (2023-2028) 6.4 United States 6.5 Canada 7 Europe 7.1 Europe Healthcare Nanotechnology (Nanomedicine) Market Size (2017-2028) 7.2 Europe Healthcare Nanotechnology (Nanomedicine) Market Size by Country (2017-2022) 7.3 Europe Healthcare Nanotechnology (Nanomedicine) Market Size by Country (2023-2028) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Healthcare Nanotechnology (Nanomedicine) Market Size (2017-2028) 8.2 Asia-Pacific Healthcare Nanotechnology (Nanomedicine) Market Size by Country (2017-2022) 8.3 Asia-Pacific Healthcare Nanotechnology (Nanomedicine) Market Size by Country (2023-2028) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 9 Latin America 9.1 Latin America Healthcare Nanotechnology (Nanomedicine) Market Size (2017-2028) 9.2 Latin America Healthcare Nanotechnology (Nanomedicine) Market Size by Country (2017-2022) 9.3 Latin America Healthcare Nanotechnology (Nanomedicine) Market Size by Country (2023-2028) 9.4 Mexico 9.5 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Healthcare Nanotechnology (Nanomedicine) Market Size (2017-2028) 10.2 Middle East & Africa Healthcare Nanotechnology (Nanomedicine) Market Size by Country (2017-2022) 10.3 Middle East & Africa Healthcare Nanotechnology (Nanomedicine) Market Size by Country (2023-2028) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 11 Key Players Profiles 11.1 Amgen 11.1.1 Amgen Company Detail 11.1.2 Amgen Business Overview 11.1.3 Amgen Healthcare Nanotechnology (Nanomedicine) Introduction 11.1.4 Amgen Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2017-2022) 11.1.5 Amgen Recent Development 11.2 Teva Pharmaceuticals 11.2.1 Teva Pharmaceuticals Company Detail 11.2.2 Teva Pharmaceuticals Business Overview 11.2.3 Teva Pharmaceuticals Healthcare Nanotechnology (Nanomedicine) Introduction 11.2.4 Teva Pharmaceuticals Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2017-2022) 11.2.5 Teva Pharmaceuticals Recent Development 11.3 Abbott 11.3.1 Abbott Company Detail 11.3.2 Abbott Business Overview 11.3.3 Abbott Healthcare Nanotechnology (Nanomedicine) Introduction 11.3.4 Abbott Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2017-2022) 11.3.5 Abbott Recent Development 11.4 UCB 11.4.1 UCB Company Detail 11.4.2 UCB Business Overview 11.4.3 UCB Healthcare Nanotechnology (Nanomedicine) Introduction 11.4.4 UCB Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2017-2022) 11.4.5 UCB Recent Development 11.5 Roche 11.5.1 Roche Company Detail 11.5.2 Roche Business Overview 11.5.3 Roche Healthcare Nanotechnology (Nanomedicine) Introduction 11.5.4 Roche Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2017-2022) 11.5.5 Roche Recent Development 11.6 Celgene 11.6.1 Celgene Company Detail 11.6.2 Celgene Business Overview 11.6.3 Celgene Healthcare Nanotechnology (Nanomedicine) Introduction 11.6.4 Celgene Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2017-2022) 11.6.5 Celgene Recent Development 11.7 Sanofi 11.7.1 Sanofi Company Detail 11.7.2 Sanofi Business Overview 11.7.3 Sanofi Healthcare Nanotechnology (Nanomedicine) Introduction 11.7.4 Sanofi Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2017-2022) 11.7.5 Sanofi Recent Development 11.8 Merck & Co 11.8.1 Merck & Co Company Detail 11.8.2 Merck & Co Business Overview 11.8.3 Merck & Co Healthcare Nanotechnology (Nanomedicine) Introduction 11.8.4 Merck & Co Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2017-2022) 11.8.5 Merck & Co Recent Development 11.9 Biogen 11.9.1 Biogen Company Detail 11.9.2 Biogen Business Overview 11.9.3 Biogen Healthcare Nanotechnology (Nanomedicine) Introduction 11.9.4 Biogen Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2017-2022) 11.9.5 Biogen Recent Development 11.10 Stryker 11.10.1 Stryker Company Detail 11.10.2 Stryker Business Overview 11.10.3 Stryker Healthcare Nanotechnology (Nanomedicine) Introduction 11.10.4 Stryker Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2017-2022) 11.10.5 Stryker Recent Development 11.11 Gilead Sciences 11.11.1 Gilead Sciences Company Detail 11.11.2 Gilead Sciences Business Overview 11.11.3 Gilead Sciences Healthcare Nanotechnology (Nanomedicine) Introduction 11.11.4 Gilead Sciences Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2017-2022) 11.11.5 Gilead Sciences Recent Development 11.12 Pfizer 11.12.1 Pfizer Company Detail 11.12.2 Pfizer Business Overview 11.12.3 Pfizer Healthcare Nanotechnology (Nanomedicine) Introduction 11.12.4 Pfizer Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2017-2022) 11.12.5 Pfizer Recent Development 11.13 3M Company 11.13.1 3M Company Company Detail 11.13.2 3M Company Business Overview 11.13.3 3M Company Healthcare Nanotechnology (Nanomedicine) Introduction 11.13.4 3M Company Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2017-2022) 11.13.5 3M Company Recent Development 11.14 Johnson & Johnson 11.14.1 Johnson & Johnson Company Detail 11.14.2 Johnson & Johnson Business Overview 11.14.3 Johnson & Johnson Healthcare Nanotechnology (Nanomedicine) Introduction 11.14.4 Johnson & Johnson Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2017-2022) 11.14.5 Johnson & Johnson Recent Development 11.15 SmitH& Nephew 11.15.1 SmitH& Nephew Company Detail 11.15.2 SmitH& Nephew Business Overview 11.15.3 SmitH& Nephew Healthcare Nanotechnology (Nanomedicine) Introduction 11.15.4 SmitH& Nephew Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2017-2022) 11.15.5 SmitH& Nephew Recent Development 11.16 Leadiant Biosciences 11.16.1 Leadiant Biosciences Company Detail 11.16.2 Leadiant Biosciences Business Overview 11.16.3 Leadiant Biosciences Healthcare Nanotechnology (Nanomedicine) Introduction 11.16.4 Leadiant Biosciences Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2017-2022) 11.16.5 Leadiant Biosciences Recent Development 11.17 Kyowa Hakko Kirin 11.17.1 Kyowa Hakko Kirin Company Detail 11.17.2 Kyowa Hakko Kirin Business Overview 11.17.3 Kyowa Hakko Kirin Healthcare Nanotechnology (Nanomedicine) Introduction 11.17.4 Kyowa Hakko Kirin Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2017-2022) 11.17.5 Kyowa Hakko Kirin Recent Development 11.18 Takeda 11.18.1 Takeda Company Detail 11.18.2 Takeda Business Overview 11.18.3 Takeda Healthcare Nanotechnology (Nanomedicine) Introduction 11.18.4 Takeda Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2017-2022) 11.18.5 Takeda Recent Development 11.19 Ipsen 11.19.1 Ipsen Company Detail 11.19.2 Ipsen Business Overview 11.19.3 Ipsen Healthcare Nanotechnology (Nanomedicine) Introduction 11.19.4 Ipsen Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2017-2022) 11.19.5 Ipsen Recent Development 11.20 Endo International 11.20.1 Endo International Company Detail 11.20.2 Endo International Business Overview 11.20.3 Endo International Healthcare Nanotechnology (Nanomedicine) Introduction 11.20.4 Endo International Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2017-2022) 11.20.5 Endo International Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Healthcare Nanotechnology (Nanomedicine) Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of Nanomedicine Table 3. Key Players of Nano Medical Devices Table 4. Key Players of Nano Diagnosis Table 5. Key Players of Other Table 6. Global Healthcare Nanotechnology (Nanomedicine) Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 7. Global Healthcare Nanotechnology (Nanomedicine) Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 8. Global Healthcare Nanotechnology (Nanomedicine) Market Size by Region (2017-2022) & (US$ Million) Table 9. Global Healthcare Nanotechnology (Nanomedicine) Market Share by Region (2017-2022) Table 10. Global Healthcare Nanotechnology (Nanomedicine) Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 11. Global Healthcare Nanotechnology (Nanomedicine) Market Share by Region (2023-2028) Table 12. Healthcare Nanotechnology (Nanomedicine) Market Trends Table 13. Healthcare Nanotechnology (Nanomedicine) Market Drivers Table 14. Healthcare Nanotechnology (Nanomedicine) Market Challenges Table 15. Healthcare Nanotechnology (Nanomedicine) Market Restraints Table 16. Global Healthcare Nanotechnology (Nanomedicine) Revenue by Players (2017-2022) & (US$ Million) Table 17. Global Healthcare Nanotechnology (Nanomedicine) Market Share by Players (2017-2022) Table 18. Global Top Healthcare Nanotechnology (Nanomedicine) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Healthcare Nanotechnology (Nanomedicine) as of 2021) Table 19. Ranking of Global Top Healthcare Nanotechnology (Nanomedicine) Companies by Revenue (US$ Million) in 2021 Table 20. Global 5 Largest Players Market Share by Healthcare Nanotechnology (Nanomedicine) Revenue (CR5 and HHI) & (2017-2022) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Healthcare Nanotechnology (Nanomedicine) Product Solution and Service Table 23. Date of Enter into Healthcare Nanotechnology (Nanomedicine) Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Healthcare Nanotechnology (Nanomedicine) Market Size by Type (2017-2022) & (US$ Million) Table 26. Global Healthcare Nanotechnology (Nanomedicine) Revenue Market Share by Type (2017-2022) Table 27. Global Healthcare Nanotechnology (Nanomedicine) Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 28. Global Healthcare Nanotechnology (Nanomedicine) Revenue Market Share by Type (2023-2028) Table 29. Global Healthcare Nanotechnology (Nanomedicine) Market Size by Application (2017-2022) & (US$ Million) Table 30. Global Healthcare Nanotechnology (Nanomedicine) Revenue Market Share by Application (2017-2022) Table 31. Global Healthcare Nanotechnology (Nanomedicine) Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 32. Global Healthcare Nanotechnology (Nanomedicine) Revenue Market Share by Application (2023-2028) Table 33. North America Healthcare Nanotechnology (Nanomedicine) Market Size by Country (2017-2022) & (US$ Million) Table 34. North America Healthcare Nanotechnology (Nanomedicine) Market Size by Country (2023-2028) & (US$ Million) Table 35. Europe Healthcare Nanotechnology (Nanomedicine) Market Size by Country (2017-2022) & (US$ Million) Table 36. Europe Healthcare Nanotechnology (Nanomedicine) Market Size by Country (2023-2028) & (US$ Million) Table 37. Asia-Pacific Healthcare Nanotechnology (Nanomedicine) Market Size by Region (2017-2022) & (US$ Million) Table 38. Asia-Pacific Healthcare Nanotechnology (Nanomedicine) Market Size by Region (2023-2028) & (US$ Million) Table 39. Latin America Healthcare Nanotechnology (Nanomedicine) Market Size by Country (2017-2022) & (US$ Million) Table 40. Latin America Healthcare Nanotechnology (Nanomedicine) Market Size by Country (2023-2028) & (US$ Million) Table 41. Middle East & Africa Healthcare Nanotechnology (Nanomedicine) Market Size by Country (2017-2022) & (US$ Million) Table 42. Middle East & Africa Healthcare Nanotechnology (Nanomedicine) Market Size by Country (2023-2028) & (US$ Million) Table 43. Amgen Company Detail Table 44. Amgen Business Overview Table 45. Amgen Healthcare Nanotechnology (Nanomedicine) Product Table 46. Amgen Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2017-2022) & (US$ Million) Table 47. Amgen Recent Development Table 48. Teva Pharmaceuticals Company Detail Table 49. Teva Pharmaceuticals Business Overview Table 50. Teva Pharmaceuticals Healthcare Nanotechnology (Nanomedicine) Product Table 51. Teva Pharmaceuticals Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2017-2022) & (US$ Million) Table 52. Teva Pharmaceuticals Recent Development Table 53. Abbott Company Detail Table 54. Abbott Business Overview Table 55. Abbott Healthcare Nanotechnology (Nanomedicine) Product Table 56. Abbott Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2017-2022) & (US$ Million) Table 57. Abbott Recent Development Table 58. UCB Company Detail Table 59. UCB Business Overview Table 60. UCB Healthcare Nanotechnology (Nanomedicine) Product Table 61. UCB Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2017-2022) & (US$ Million) Table 62. UCB Recent Development Table 63. Roche Company Detail Table 64. Roche Business Overview Table 65. Roche Healthcare Nanotechnology (Nanomedicine) Product Table 66. Roche Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2017-2022) & (US$ Million) Table 67. Roche Recent Development Table 68. Celgene Company Detail Table 69. Celgene Business Overview Table 70. Celgene Healthcare Nanotechnology (Nanomedicine) Product Table 71. Celgene Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2017-2022) & (US$ Million) Table 72. Celgene Recent Development Table 73. Sanofi Company Detail Table 74. Sanofi Business Overview Table 75. Sanofi Healthcare Nanotechnology (Nanomedicine) Product Table 76. Sanofi Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2017-2022) & (US$ Million) Table 77. Sanofi Recent Development Table 78. Merck & Co Company Detail Table 79. Merck & Co Business Overview Table 80. Merck & Co Healthcare Nanotechnology (Nanomedicine) Product Table 81. Merck & Co Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2017-2022) & (US$ Million) Table 82. Merck & Co Recent Development Table 83. Biogen Company Detail Table 84. Biogen Business Overview Table 85. Biogen Healthcare Nanotechnology (Nanomedicine) Product Table 86. Biogen Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2017-2022) & (US$ Million) Table 87. Biogen Recent Development Table 88. Stryker Company Detail Table 89. Stryker Business Overview Table 90. Stryker Healthcare Nanotechnology (Nanomedicine) Product Table 91. Stryker Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2017-2022) & (US$ Million) Table 92. Stryker Recent Development Table 93. Gilead Sciences Company Detail Table 94. Gilead Sciences Business Overview Table 95. Gilead Sciences Healthcare Nanotechnology (Nanomedicine)Product Table 96. Gilead Sciences Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2017-2022) & (US$ Million) Table 97. Gilead Sciences Recent Development Table 98. Pfizer Company Detail Table 99. Pfizer Business Overview Table 100. Pfizer Healthcare Nanotechnology (Nanomedicine)Product Table 101. Pfizer Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2017-2022) & (US$ Million) Table 102. Pfizer Recent Development Table 103. 3M Company Company Detail Table 104. 3M Company Business Overview Table 105. 3M Company Healthcare Nanotechnology (Nanomedicine)Product Table 106. 3M Company Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2017-2022) & (US$ Million) Table 107. 3M Company Recent Development Table 108. Johnson & Johnson Company Detail Table 109. Johnson & Johnson Business Overview Table 110. Johnson & Johnson Healthcare Nanotechnology (Nanomedicine)Product Table 111. Johnson & Johnson Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2017-2022) & (US$ Million) Table 112. Johnson & Johnson Recent Development Table 113. SmitH& Nephew Company Detail Table 114. SmitH& Nephew Business Overview Table 115. SmitH& Nephew Healthcare Nanotechnology (Nanomedicine)Product Table 116. SmitH& Nephew Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2017-2022) & (US$ Million) Table 117. SmitH& Nephew Recent Development Table 118. Leadiant Biosciences Company Detail Table 119. Leadiant Biosciences Business Overview Table 120. Leadiant Biosciences Healthcare Nanotechnology (Nanomedicine)Product Table 121. Leadiant Biosciences Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2017-2022) & (US$ Million) Table 122. Leadiant Biosciences Recent Development Table 123. Kyowa Hakko Kirin Company Detail Table 124. Kyowa Hakko Kirin Business Overview Table 125. Kyowa Hakko Kirin Healthcare Nanotechnology (Nanomedicine)Product Table 126. Kyowa Hakko Kirin Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2017-2022) & (US$ Million) Table 127. Kyowa Hakko Kirin Recent Development Table 128. Takeda Company Detail Table 129. Takeda Business Overview Table 130. Takeda Healthcare Nanotechnology (Nanomedicine)Product Table 131. Takeda Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2017-2022) & (US$ Million) Table 132. Takeda Recent Development Table 133. Ipsen Company Detail Table 134. Ipsen Business Overview Table 135. Ipsen Healthcare Nanotechnology (Nanomedicine)Product Table 136. Ipsen Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2017-2022) & (US$ Million) Table 137. Ipsen Recent Development Table 138. Endo International Company Detail Table 139. Endo International Business Overview Table 140. Endo International Healthcare Nanotechnology (Nanomedicine)Product Table 141. Endo International Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2017-2022) & (US$ Million) Table 142. Endo International Recent Development Table 143. Research Programs/Design for This Report Table 144. Key Data Information from Secondary Sources Table 145. Key Data Information from Primary Sources List of Figures Figure 1. Global Healthcare Nanotechnology (Nanomedicine) Market Share by Type: 2021 VS 2028 Figure 2. Nanomedicine Features Figure 3. Nano Medical Devices Features Figure 4. Nano Diagnosis Features Figure 5. Other Features Figure 6. Global Healthcare Nanotechnology (Nanomedicine) Market Share by Application in 2021 & 2028 Figure 7. Anticancer Case Studies Figure 8. CNS Product Case Studies Figure 9. Anti-infective Case Studies Figure 10. Other Case Studies Figure 11. Healthcare Nanotechnology (Nanomedicine) Report Years Considered Figure 12. Global Healthcare Nanotechnology (Nanomedicine) Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 13. Global Healthcare Nanotechnology (Nanomedicine) Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 14. Global Healthcare Nanotechnology (Nanomedicine) Market Share by Region: 2021 VS 2028 Figure 15. Global Healthcare Nanotechnology (Nanomedicine) Market Share by Players in 2021 Figure 16. Global Top Healthcare Nanotechnology (Nanomedicine) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Healthcare Nanotechnology (Nanomedicine) as of 2021) Figure 17. The Top 10 and 5 Players Market Share by Healthcare Nanotechnology (Nanomedicine) Revenue in 2021 Figure 18. North America Healthcare Nanotechnology (Nanomedicine) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 19. North America Healthcare Nanotechnology (Nanomedicine) Market Share by Country (2017-2028) Figure 20. United States Healthcare Nanotechnology (Nanomedicine) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 21. Canada Healthcare Nanotechnology (Nanomedicine) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. Europe Healthcare Nanotechnology (Nanomedicine) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. Europe Healthcare Nanotechnology (Nanomedicine) Market Share by Country (2017-2028) Figure 24. Germany Healthcare Nanotechnology (Nanomedicine) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. France Healthcare Nanotechnology (Nanomedicine) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. U.K. Healthcare Nanotechnology (Nanomedicine) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Italy Healthcare Nanotechnology (Nanomedicine) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Russia Healthcare Nanotechnology (Nanomedicine) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Nordic Countries Healthcare Nanotechnology (Nanomedicine) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Asia-Pacific Healthcare Nanotechnology (Nanomedicine) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Asia-Pacific Healthcare Nanotechnology (Nanomedicine) Market Share by Region (2017-2028) Figure 32. China Healthcare Nanotechnology (Nanomedicine) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. Japan Healthcare Nanotechnology (Nanomedicine) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. South Korea Healthcare Nanotechnology (Nanomedicine) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Southeast Asia Healthcare Nanotechnology (Nanomedicine) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. India Healthcare Nanotechnology (Nanomedicine) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Australia Healthcare Nanotechnology (Nanomedicine) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Latin America Healthcare Nanotechnology (Nanomedicine) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Latin America Healthcare Nanotechnology (Nanomedicine) Market Share by Country (2017-2028) Figure 40. Mexico Healthcare Nanotechnology (Nanomedicine) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Brazil Healthcare Nanotechnology (Nanomedicine) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Middle East & Africa Healthcare Nanotechnology (Nanomedicine) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Middle East & Africa Healthcare Nanotechnology (Nanomedicine) Market Share by Country (2017-2028) Figure 44. Turkey Healthcare Nanotechnology (Nanomedicine) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 45. Saudi Arabia Healthcare Nanotechnology (Nanomedicine) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 46. Amgen Revenue Growth Rate in Healthcare Nanotechnology (Nanomedicine) Business (2017-2022) Figure 47. Teva Pharmaceuticals Revenue Growth Rate in Healthcare Nanotechnology (Nanomedicine) Business (2017-2022) Figure 48. Abbott Revenue Growth Rate in Healthcare Nanotechnology (Nanomedicine) Business (2017-2022) Figure 49. UCB Revenue Growth Rate in Healthcare Nanotechnology (Nanomedicine) Business (2017-2022) Figure 50. Roche Revenue Growth Rate in Healthcare Nanotechnology (Nanomedicine) Business (2017-2022) Figure 51. Celgene Revenue Growth Rate in Healthcare Nanotechnology (Nanomedicine) Business (2017-2022) Figure 52. Sanofi Revenue Growth Rate in Healthcare Nanotechnology (Nanomedicine) Business (2017-2022) Figure 53. Merck & Co Revenue Growth Rate in Healthcare Nanotechnology (Nanomedicine) Business (2017-2022) Figure 54. Biogen Revenue Growth Rate in Healthcare Nanotechnology (Nanomedicine) Business (2017-2022) Figure 55. Stryker Revenue Growth Rate in Healthcare Nanotechnology (Nanomedicine) Business (2017-2022) Figure 56. Gilead Sciences Revenue Growth Rate in Healthcare Nanotechnology (Nanomedicine) Business (2017-2022) Figure 57. Pfizer Revenue Growth Rate in Healthcare Nanotechnology (Nanomedicine) Business (2017-2022) Figure 58. 3M Company Revenue Growth Rate in Healthcare Nanotechnology (Nanomedicine) Business (2017-2022) Figure 59. Johnson & Johnson Revenue Growth Rate in Healthcare Nanotechnology (Nanomedicine) Business (2017-2022) Figure 60. SmitH& Nephew Revenue Growth Rate in Healthcare Nanotechnology (Nanomedicine) Business (2017-2022) Figure 61. Leadiant Biosciences Revenue Growth Rate in Healthcare Nanotechnology (Nanomedicine) Business (2017-2022) Figure 62. Kyowa Hakko Kirin Revenue Growth Rate in Healthcare Nanotechnology (Nanomedicine) Business (2017-2022) Figure 63. Takeda Revenue Growth Rate in Healthcare Nanotechnology (Nanomedicine) Business (2017-2022) Figure 64. Ipsen Revenue Growth Rate in Healthcare Nanotechnology (Nanomedicine) Business (2017-2022) Figure 65. Endo International Revenue Growth Rate in Healthcare Nanotechnology (Nanomedicine) Business (2017-2022) Figure 66. Bottom-up and Top-down Approaches for This Report Figure 67. Data Triangulation Figure 68. Key Executives Interviewed

Amgen Teva Pharmaceuticals Abbott UCB Roche Celgene Sanofi Merck & Co Biogen Stryker Gilead Sciences Pfizer 3M Company Johnson & Johnson SmitH& Nephew Leadiant Biosciences Kyowa Hakko Kirin Takeda Ipsen Endo International